Santhera Pharmaceuticals Aktie

12,86CHF -1,46CHF -10,20%
Santhera Pharmaceuticals für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A3EJMQ / ISIN: CH1276028821

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Personal

2019 2020 2021 2022 2023
Personal am Ende des Jahres 117 91 43 45 44
Umsatz pro Mitarbeiter in Mio. EUR 0,64 0,16 -0,04 0,16 2,31

Bilanz (in Mio. CHF) - Aktiva

2019 2020 2021 2022 2023
Summe Umlaufvermögen 49 18 25 3 35
Summe Anlagevermögen 66 71 66 61 75
Summe Aktiva 115 89 91 64 110

Bilanz (in Mio. CHF) - Passiva

2019 2020 2021 2022 2023
Summe Fremdkapital 94 95 90 107 50
Summe Eigenkapital 21 -6 1 -44 60
Summe Passiva 115 89 91 64 110

Adresse

Hohenrainstrasse 24, 4133 Pratteln
Telefon +41 (61) 906-89-50
Fax +41 (61) 906-89-51
Internet http://www.santhera.com

Management

Ana de Vera
Deputy Chief Marketing Officer & Head-Development
Andreas Missy
Chief of Staff
Bradley Carl Meyer
Director
Catherine Isted
Chief Financial Officer
Dario Eklund
Chief Executive Officer
Geert Jan van Daal
Chief Commercial Officer
Günther Metz
Head-Business Development
Marc Schrader
Chief Technology Officer
Neville Kodkani
Head-Global Marketing & Partner Management
Oliver P. Kronenberg
Secretary, Chief Legal Officer & General Counsel
Oliver Strub
Head-Compliance
Otto Schwarz
Director
Philipp Gutzwiller
Independent Director
Sabine Pilot
Head-Clinical Development Operations
Sarah Holmes-Klotz
Global Head-People & Culture
Shabir Hasham
Executive Director & Chief Medical Officer
Thomas Meier
Chairman